Sanofi (SNY) Gains from Investment Securities (2009 - 2026)

Sanofi (SNY) has 18 years of Gains from Investment Securities data on file, last reported at $41.0 million in Q1 2026.

• Quarterly Gains from Investment Securities rose 532.83% year-over-year to $41.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$275.7 million (down 29.83% YoY) and the FY2025 annual result came in at -$409.7 million, down 4.77% from the prior year.
• Gains from Investment Securities rose to $41.0 million in Q1 2026 per SNY's latest filing, from -$121.1 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $41.0 million in Q1 2026, with the low at -$136.8 million in Q3 2025.
• Average Gains from Investment Securities over 5 years is -$33.7 million, with a median of -$12.0 million recorded in 2023.
• Year-over-year, Gains from Investment Securities slumped 1456.83% in 2025 and jumped 532.83% in 2026.
• Sanofi's Gains from Investment Securities stood at $12.2 million in 2022, then tumbled by 917.31% to -$100.1 million in 2023, then slipped by 2.52% to -$102.6 million in 2024, then dropped by 18.01% to -$121.1 million in 2025, then jumped by 133.85% to $41.0 million in 2026.
• Business Quant data shows SNY's Gains from Investment Securities at $41.0 million in Q1 2026, -$121.1 million in Q4 2025, and -$136.8 million in Q3 2025.